These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2163257)

  • 1. Cyclosporin abrogates virus-specific T-cell control of EBV-induced B-cell lymphoproliferation.
    York LJ; Qualtiere LF
    Viral Immunol; 1990; 3(2):127-36. PubMed ID: 2163257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
    J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A abrogates proliferation of T cells and generation of suppressor and cytotoxic T-cell function induced by Epstein-Barr virus.
    Palacios R
    Immunobiology; 1981; 160(3-4):321-9. PubMed ID: 6276295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A.
    Rickinson AB; Rowe M; Hart IJ; Yao QY; Henderson LE; Rabin H; Epstein MA
    Cell Immunol; 1984 Sep; 87(2):646-58. PubMed ID: 6088089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A renders target cells resistant to immune cytolysis.
    Hudnall SD
    Eur J Immunol; 1991 Jan; 21(1):221-6. PubMed ID: 1846819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cyclosporin A on functions of specific murine T cell clones: inhibition of proliferation, lymphokine secretion and cytotoxicity.
    Weiss J; Schwinzer B; Kirchner H; Gemsa D; Resch K
    Immunobiology; 1986 Apr; 171(3):234-51. PubMed ID: 3086216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclosporin-A (CsA) on the ability of T lymphocyte subsets to inhibit the proliferation of autologous EBV-transformed B cells.
    Bejarano MT; Masucci MG; Ernberg I; Klein E; Klein G
    Int J Cancer; 1985 Mar; 35(3):327-33. PubMed ID: 2982748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of cyclosporin A on the early responses of B and T cells to Epstein-Barr virus infection.
    Irving WL; Lockwood D; Lydyard PM
    Immunol Lett; 1986 Oct; 13(4):173-8. PubMed ID: 3021615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT; Bluestein HG; Zvaifler NJ
    J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines.
    Bird AG; McLachlan SM; Britton S
    Nature; 1981 Jan; 289(5795):300-1. PubMed ID: 6256660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.
    Meij P; Bloemena E; Palmen N; Brink A; Vervoort MB; Meijer CJ; Middeldorp JM
    Cell Immunol; 2001 Feb; 208(1):25-33. PubMed ID: 11277616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.
    Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA
    Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytolytic T cell reactivity to Epstein-Barr virus is lost during in vitro T cell expansion.
    Carlens S; Liu D; Ringdén O; Aschan J; Christensson B; Levitsky V; Dilber MS
    J Hematother Stem Cell Res; 2002 Aug; 11(4):669-74. PubMed ID: 12201955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants.
    Moss DJ; Misko IS; Burrows SR; Burman K; McCarthy R; Sculley TB
    Nature; 1988 Feb; 331(6158):719-21. PubMed ID: 2830541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell-derived interleukin 1 (IL-1)-like factor. I. Relationship of production of IL-1-like factor to accessory cell function of Epstein-Barr virus-transformed human B-lymphoblast lines.
    Matsushima K; Kuang YD; Tosato G; Hopkins SJ; Oppenheim JJ
    Cell Immunol; 1985 Sep; 94(2):406-17. PubMed ID: 2992808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A.
    Crawford DH; Sweny P; Edwards JM; Janossy G; Hoffbrand AV
    Lancet; 1981 Jan; 1(8210):10-2. PubMed ID: 6109048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.
    Sun Q; Burton RL; Pollok KE; Emanuel DJ; Lucas KG
    Cell Immunol; 1999 Aug; 195(2):81-8. PubMed ID: 10448007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells.
    Chu E; Umetsu D; Lareau M; Schneeberger E; Geha RS
    Eur J Immunol; 1984 Apr; 14(4):291-8. PubMed ID: 6327319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen presentation by EBV-B cells to resting and activated T cells: role of interleukin 1.
    Chu ET; Lareau M; Rosenwasser LJ; Dinarello CA; Geha RS
    J Immunol; 1985 Mar; 134(3):1676-81. PubMed ID: 2981918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340.
    Ulaeto D; Wallace L; Morgan A; Morein B; Rickinson AB
    Eur J Immunol; 1988 Nov; 18(11):1689-97. PubMed ID: 2904885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.